Added to YB: 2025-09-17
Pitch date: 2025-09-14
FTRE [neutral]
Fortrea Holdings Inc.
+55.03%
current return
Author Info
Company Info
Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.
Market Cap
$961.9M
Pitch Price
$10.14
Price Target
N/A
Dividend
N/A
EV/EBITDA
85.02
P/E
-0.92
EV/Sales
0.73
Sector
Life Sciences Tools and Services
Category
turnaround
3 Healthcare Stocks on My Radar - Fortrea Holdings Inc.
FTRE (quick overview): Biotech CRO spun from LabCorp June 2023 w/ heavy debt burden amid weak biotech funding cycle. Global scale ~100 countries, 15K employees, 5,900+ trials expertise in oncology/clinical pharm. High customer concentration risk, negative margins, goodwill impairments. New CEO Aug, ongoing restructuring. Turnaround candidate in fragmented space.
Read full article (2 min)